C (Citigroup, Inc.) is set to announce its Q2'26 results on July 14, after the market closes. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).For Q2'26, revenue estimate is 23.56 billion USD with EPS (earnings per share) anticipated at 2.72 USD. Learn more details at C Financ…
HELE (Helen of Troy Limited) is set to announce its Q1'26 results on July 08, after the market closes. The earnings are expected to be disclosed at 6:45 AM ET (10:45 AM UTC).For Q1'26, revenue estimate is 374.55 million USD with EPS (earnings per share) anticipated at 0.02 USD. Learn more details a…
KMTS (Kestra Medical Technologies, Ltd.) is set to announce its Q4'25 results on July 14, before the market opens. The earnings are expected to be disclosed at 4:01 PM ET (8:01 PM UTC).For Q4'25, revenue estimate is 26.48 million USD with EPS (earnings per share) anticipated at (0.59) USD. Learn mo…
AZZ (AZZ Inc.) is set to announce its Q1'26 results on July 08, before the market opens. The earnings are expected to be disclosed at 4:00 PM ET (8:00 PM UTC).For Q1'26, revenue estimate is 434.58 million USD with EPS (earnings per share) anticipated at 1.69 USD. Learn more details at AZZ Financial…
BAC (Bank of America Corporation) is set to announce its Q2'26 results on July 14, after the market closes. The earnings are expected to be disclosed at 6:45 AM ET (10:45 AM UTC).For Q2'26, revenue estimate is 30.59 billion USD with EPS (earnings per share) anticipated at 1.12 USD. Learn more detai…
GS (Goldman Sachs Group, Inc. (The)) is set to announce its Q2'26 results on July 14, after the market closes. The earnings are expected to be disclosed at 7:30 AM ET (11:30 AM UTC).For Q2'26, revenue estimate is 16.13 billion USD with EPS (earnings per share) anticipated at 14.20 USD. Learn more d…
JPM (JP Morgan Chase & Co.) is set to announce its Q2'26 results on July 14, after the market closes. The earnings are expected to be disclosed at 7:00 AM ET (11:00 AM UTC).For Q2'26, revenue estimate is 50.39 billion USD with EPS (earnings per share) anticipated at 5.50 USD. Learn more details at…
LEVI (Levi Strauss & Co) is set to announce its Q2'26 results on July 08, before the market opens. The earnings are expected to be disclosed at 4:00 PM ET (8:00 PM UTC).For Q2'26, revenue estimate is 1.52 billion USD with EPS (earnings per share) anticipated at 0.24 USD. Learn more details at LEVI…
PSMT (PriceSmart, Inc.) is set to announce its Q3'26 results on July 08, before the market opens. The earnings are expected to be disclosed at 4:00 PM ET (8:00 PM UTC).For Q3'26, revenue estimate is 1.43 billion USD with EPS (earnings per share) anticipated at 1.32 USD. Learn more details at PSMT F…
AC Immune to Showcase Neurodegenerative Disease Pipeline with Three Presentations at AAIC® 2026Lausanne, Switzerland, July 7, 2026 -- AC Immune SA NASDAQ:ACIU, a clinical-stage biopharmaceutical company pioneering precision therapeutics for neurodegenerative diseases, today announces three presenta…
AS Pro Kapital Grupp (the Issuer) announces that it has exercised its right under Clause 1.1.18 of the Terms and Conditions of the fixed rate unsecured non-convertible bonds (ISIN EE3300001676; the Bonds) to extend the maturity date of the Bonds by two years.Pursuant to the Terms and Conditions, th…
Vancouver, BC, July 07, 2026 (GLOBE NEWSWIRE) -- Aben Gold Corp. (TSX-V: ABM) (OTCID: ABNAF) (Frankfurt: ML1) (“Aben” or “the Company”) is pleased to provide an update on the Company's fully funded 2026 exploration program at its 100%-owned Justin Gold-Tungsten Project, located in southeastern Yuko…
BROOMFIELD, Colo., July 07, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) NASDAQ:ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back p…
Leading Industry Experts to Participate in Interactive Panel SessionsCompany to Present Technical Paper on Scalable Quantum Dot Lasers for AI DatacomGOLETA, Calif., July 07, 2026 (GLOBE NEWSWIRE) -- Aeluma, Inc. NASDAQ:ALMU, a semiconductor company specializing in high-performance, scalable technol…
VANCOUVER, British Columbia, July 07, 2026 (GLOBE NEWSWIRE) -- American Lithium Corp. (“American Lithium” or the “Company”) (TSX-V:LI | OTCQX:AMLIF | Frankfurt:5LA1 welcomes the official confirmation of Keiko Fujimori’s presidential election victory and believes this result marks a positive outlook…
Pivotal Phase 3 trial enrolls 850 patients, exceeding original projectionsStudy completion on track: symptomatic data readout - Q1 2027, disease-modifying data readout - Q1 2028Company positions for two NDA submissions following each readoutMALVERN, Pa., July 07, 2026 (GLOBE NEWSWIRE) -- Annovis Bi…
Company advances final site-specific diligence for Midwest Headwaters ARC development opportunity with existing industrial infrastructure, substantial expansion acreage, and strategic proximity to rapidly growing LFP battery manufacturing capacityRENO, Nev., July 07, 2026 (GLOBE NEWSWIRE) -- Aqua M…
WARREN, N.J., July 07, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. NASDAQ:AQST ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, announced today that the Aqu…
WAYNE, Pa., July 07, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. NASDAQ:AVTX, a clinical stage biotechnology company fully dedicated to developing therapeutics targeting the IL-1β pathway for immune-mediated inflammatory diseases, today announced that management will host one-on-one investor…
The FOCUS-2 trial in children complements the recently announced FOCUS-3 trial in adolescents with ADHDNEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. NASDAQ:AXSM, a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today a…
